Logo image
Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients
Journal article   Peer reviewed

Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients

Paulo Henrique Rosado-de-Castro, Felipe da Rocha Schmidt, Valeria Battistella, Sergio Augusto Lopes de Souza, Bianca Gutfilen, Regina Coeli dos Santos Goldenberg, Tais Hanae Kasai-Brunswick, Leandro Vairo, Rafaella Monteiro Silva, Eduardo Wajnberg, …
Regenerative medicine, Vol.8(2), pp.145-155
03/01/2013
DOI: 10.2217/RME.13.2
PMID: 23477395

View Online

Abstract

Aims: To assess the biodistribution of bone marrow mononuclear cells (BMMNC) delivered by different routes in patients with subacute middle cerebral artery ischemic stroke. Patients & methods: This was a nonrandomized, open-label Phase I clinical trial. After bone marrow harvesting, BMMNCs were labeled with technetium-99m and intra-arterially or intravenously delivered together with the unlabeled cells. Scintigraphies were carried out at 2 and 24 h after cell transplantation. Clinical follow-up was continued for 6 months. Results: Twelve patients were included, between 19 and 89 days after stroke, and received 1-5 x 10(8) BMMNCs. The intra-arterial group had greater radioactive counts in the liver and spleen and lower counts in the lungs at 2 and 24 h, while in the brain they were low and similar for both routes. Conclusion: BMMNC labeling with technetium-99m allowed imaging for up to 24 h after intra-arterial or intravenous injection in stroke patients.
Cell & Tissue Engineering Cell Biology Engineering Engineering, Biomedical Life Sciences & Biomedicine Science & Technology Technology

Details

Metrics

1 Record Views
Logo image